Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Lancet 376 (9736), 190201
Being trained in GI, nutrition and obesity medicine, I wanted to be able to offer my patients something in addition to lifestyle intervention and I knew this would be impactful. In an earlier case series published in the Journal of Pediatric Gastroenterology and Nutrition , Panganiban and colleagues reported that liraglutide (Saxenda/Victoza, Novo Nordisk), in conjunction with lifestyle intervention, was effective in inducing and maintaining weight loss and improve insulin sensitivity among pediatric patients with metabolic dysfunction-associated steatohepatitis, overweight/obesity and type 2 diabetes
Additionally, GHK-Cu was added to Category 1 for non-injectable routes of administration, while injectable routes were placed into Category 2
These drugs are becoming increasingly accessible, and it is concerning that, in some cases, people can simply go online and order these kinds of medications when they may not have a full understanding of what could potentially happen
Alcohol: Your tolerance may change dramatically on GLP-1s
Green and Bishop 2019)
